中枢神経系疾患の治療法の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Central Nervous System Disorders Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8101088)・商品コード:GIR8101088
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月24日
・ページ数:131
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥379,320見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥568,980見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥758,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、中枢神経系疾患の治療法の世界市場について調べ、まとめました。種類別セグメントは、うつ病、MS、双極性障害、統合失調症、てんかん、その他等、用途別セグメントは、診療所、病院等に区分しました。中枢神経系疾患の治療法の世界市場概観、メーカー動向、メーカー別中枢神経系疾患の治療法シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・中枢神経系疾患の治療法の市場概観
・中枢神経系疾患の治療法のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・中枢神経系疾患の治療法のメーカー別販売動向、市場シェア、市場集中度、競争動向
・中枢神経系疾患の治療法の世界市場規模
・中枢神経系疾患の治療法の北米市場分析(アメリカ、カナダ、メキシコ等)
・中枢神経系疾患の治療法のアメリカ市場規模推移
・中枢神経系疾患の治療法のカナダ市場規模推移
・中枢神経系疾患の治療法のメキシコ市場規模推移
・中枢神経系疾患の治療法のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・中枢神経系疾患の治療法のドイツ市場規模推移
・中枢神経系疾患の治療法のイギリス市場規模推移
・中枢神経系疾患の治療法のロシア市場規模推移
・中枢神経系疾患の治療法のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・中枢神経系疾患の治療法の日本市場規模推移
・中枢神経系疾患の治療法の中国市場規模推移
・中枢神経系疾患の治療法の韓国市場規模推移
・中枢神経系疾患の治療法のインド市場規模推移
・中枢神経系疾患の治療法の東南アジア市場規模推移
・中枢神経系疾患の治療法の南米市場分析(ブラジル、アルゼンチン等)
・中枢神経系疾患の治療法の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・中枢神経系疾患の治療法の種類別分析/市場規模推移(うつ病、MS、双極性障害、統合失調症、てんかん、その他)
・中枢神経系疾患の治療法の用途別分析/市場規模推移(診療所、病院)
・中枢神経系疾患の治療法の市場予測(地域別予測、種類別予測、用途別予測)
・中枢神経系疾患の治療法の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.

Scope of the Report:

This report studies the Central Nervous System Disorders Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Central Nervous System Disorders Therapeutics market by product type and applications/end industries.

Depression is the dominated market of CNS Disorders Therapeutics

The global Central Nervous System Disorders Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Central Nervous System Disorders Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Eli Lilly

GlaxoSmithKline

Janssen Pharmaceuticals

Novartis

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Depression

MS

bipolar disorder

schizophrenia

epilepsy

AD

Parkinson’ s

others

Market Segment by Applications, can be divided into

Clinicals

Hospitials

【レポートの目次】

Table of Contents

1 Central Nervous System Disorders Therapeutics Market Overview

1.1 Product Overview and Scope of Central Nervous System Disorders Therapeutics

1.2 Classification of Central Nervous System Disorders Therapeutics by Types

1.2.1 Global Central Nervous System Disorders Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Types in 2017

1.2.3 Depression

1.2.4 MS

1.2.5 bipolar disorder

1.2.6 schizophrenia

1.2.7 epilepsy

1.2.8 AD

1.2.9 Parkinson’ s

1.2.10 others

1.3 Global Central Nervous System Disorders Therapeutics Market by Application

1.3.1 Global Central Nervous System Disorders Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Clinicals

1.3.3 Hospitials

1.4 Global Central Nervous System Disorders Therapeutics Market by Regions

1.4.1 Global Central Nervous System Disorders Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Central Nervous System Disorders Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Central Nervous System Disorders Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Central Nervous System Disorders Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Central Nervous System Disorders Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Central Nervous System Disorders Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Central Nervous System Disorders Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Eli Lilly

2.1.1 Business Overview

2.1.2 Central Nervous System Disorders Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Eli Lilly Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 GlaxoSmithKline

2.2.1 Business Overview

2.2.2 Central Nervous System Disorders Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Janssen Pharmaceuticals

2.3.1 Business Overview

2.3.2 Central Nervous System Disorders Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Central Nervous System Disorders Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Central Nervous System Disorders Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Central Nervous System Disorders Therapeutics Market Competition, by Players

3.1 Global Central Nervous System Disorders Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Central Nervous System Disorders Therapeutics Players Market Share

3.2.2 Top 10 Central Nervous System Disorders Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Central Nervous System Disorders Therapeutics Market Size by Regions

4.1 Global Central Nervous System Disorders Therapeutics Revenue and Market Share by Regions

4.2 North America Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Central Nervous System Disorders Therapeutics Revenue by Countries

5.1 North America Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

5.2 USA Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Central Nervous System Disorders Therapeutics Revenue by Countries

6.1 Europe Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Central Nervous System Disorders Therapeutics Revenue by Countries

7.1 Asia-Pacific Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

7.2 China Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Central Nervous System Disorders Therapeutics Revenue by Countries

8.1 South America Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Central Nervous System Disorders Therapeutics by Countries

9.1 Middle East and Africa Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Central Nervous System Disorders Therapeutics Market Segment by Type

10.1 Global Central Nervous System Disorders Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Central Nervous System Disorders Therapeutics Market Forecast by Type (2018-2023)

10.3 Depression Revenue Growth Rate (2013-2023)

10.4 MS Revenue Growth Rate (2013-2023)

10.5 bipolar disorder Revenue Growth Rate (2013-2023)

10.6 schizophrenia Revenue Growth Rate (2013-2023)

10.7 epilepsy Revenue Growth Rate (2013-2023)

10.8 AD Revenue Growth Rate (2013-2023)

10.9 Parkinson’ s Revenue Growth Rate (2013-2023)

10.10 others Revenue Growth Rate (2013-2023)

11 Global Central Nervous System Disorders Therapeutics Market Segment by Application

11.1 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Central Nervous System Disorders Therapeutics Market Forecast by Application (2018-2023)

11.3 Clinicals Revenue Growth (2013-2018)

11.4 Hospitials Revenue Growth (2013-2018)

12 Global Central Nervous System Disorders Therapeutics Market Size Forecast (2018-2023)

12.1 Global Central Nervous System Disorders Therapeutics Market Size Forecast (2018-2023)

12.2 Global Central Nervous System Disorders Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Central Nervous System Disorders Therapeutics Picture

Table Product Specifications of Central Nervous System Disorders Therapeutics

Table Global Central Nervous System Disorders Therapeutics and Revenue (Million USD) Market Split by Product Type

Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share by Types in 2017

Figure Depression Picture

Figure MS Picture

Figure bipolar disorder Picture

Figure schizophrenia Picture

Figure epilepsy Picture

Figure AD Picture

Figure Parkinson' s Picture

Figure others Picture

Table Global Central Nervous System Disorders Therapeutics Revenue (Million USD) by Application (2013-2023)

Figure Central Nervous System Disorders Therapeutics Revenue Market Share by Applications in 2017

Figure Clinicals Picture

Figure Hospitials Picture

Table Global Market Central Nervous System Disorders Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Central Nervous System Disorders Therapeutics Type and Applications

Table Eli Lilly Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Central Nervous System Disorders Therapeutics Type and Applications

Table GlaxoSmithKline Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Type and Applications

Table Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Central Nervous System Disorders Therapeutics Type and Applications

Table Novartis Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Central Nervous System Disorders Therapeutics Type and Applications

Table Pfizer Central Nervous System Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Global Central Nervous System Disorders Therapeutics Revenue (Million USD) by Players (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue Share by Players (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Share by Players in 2016

Figure Global Central Nervous System Disorders Therapeutics Revenue Share by Players in 2017

Figure Global Top 5 Players Central Nervous System Disorders Therapeutics Revenue Market Share in 2017

Figure Global Top 10 Players Central Nervous System Disorders Therapeutics Revenue Market Share in 2017

Figure Global Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue (Million USD) by Regions (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share by Regions in 2017

Figure North America Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Europe Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure South America Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

Table North America Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Central Nervous System Disorders Therapeutics Revenue Market Share by Countries in 2017

Figure USA Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Canada Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Mexico Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Central Nervous System Disorders Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Europe Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Europe Central Nervous System Disorders Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure UK Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure France Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Russia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Italy Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Central Nervous System Disorders Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Central Nervous System Disorders Therapeutics Revenue Market Share by Countries in 2017

Figure China Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Japan Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Korea Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure India Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Central Nervous System Disorders Therapeutics Revenue by Countries (2013-2018)

Table South America Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Central Nervous System Disorders Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Argentina Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Colombia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Central Nervous System Disorders Therapeutics Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Central Nervous System Disorders Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Central Nervous System Disorders Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure UAE Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Egypt Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure Nigeria Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Figure South Africa Central Nervous System Disorders Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue (Million USD) by Type (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue Share by Type (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Share by Type (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Share by Type in 2017

Table Global Central Nervous System Disorders Therapeutics Revenue Forecast by Type (2018-2023)

Figure Global Central Nervous System Disorders Therapeutics Market Share Forecast by Type (2018-2023)

Figure Global Depression Revenue Growth Rate (2013-2018)

Figure Global MS Revenue Growth Rate (2013-2018)

Figure Global bipolar disorder Revenue Growth Rate (2013-2018)

Figure Global schizophrenia Revenue Growth Rate (2013-2018)

Figure Global epilepsy Revenue Growth Rate (2013-2018)

Figure Global AD Revenue Growth Rate (2013-2018)

Figure Global Parkinson' s Revenue Growth Rate (2013-2018)

Figure Global others Revenue Growth Rate (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue by Application (2013-2018)

Table Global Central Nervous System Disorders Therapeutics Revenue Share by Application (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Share by Application (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue Share by Application in 2017

Table Global Central Nervous System Disorders Therapeutics Revenue Forecast by Application (2018-2023)

Figure Global Central Nervous System Disorders Therapeutics Market Share Forecast by Application (2018-2023)

Figure Global Clinicals Revenue Growth Rate (2013-2018)

Figure Global Hospitials Revenue Growth Rate (2013-2018)

Figure Global Central Nervous System Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Central Nervous System Disorders Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

Figure Europe Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

Figure South America Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Central Nervous System Disorders Therapeutics Revenue Market Forecast (2018-2023)



【レポートのキーワード】

中枢神経系疾患の治療法、うつ病、MS、双極性障害、統合失調症、てんかん、その他、診療所、病院

★調査レポート[中枢神経系疾患の治療法の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8101088)販売に関する免責事項を必ずご確認ください。
★調査レポート[中枢神経系疾患の治療法の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆